Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Tuberculosis Epidemiologic Studies Consortium I (TBESC I)


Peer-reviewed Journal Articles

  • Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, Albalak R, Blumberg H. Poor concordance between interferon-g release assays and tuberculin skin tests in diagnosis in latent tuberculosis infection among HIV-infected individuals. BMC Infectious Diseases 2009, 9:15 doi:10.1186/1471-2334-9-15.
  • Davidow AL, Katz D, Reves R, Bethel J, Ngong L, Tuberculosis Epidemiologic Studies Consortium. The Challenge of Multisite Epidemiologic Studies in Diverse Populations: Design and Implementation of a 22-Site Study of Tuberculosis in Foreign-Born People. Public Health Reports. 2009; 124(3): 391-399.
  • Colson PW, Couzens GL, Royce RA, Kline T, Chavez-Lindell T, Welbel S, Pang J, Davidow A, Hirsch-Moverman Y; the Tuberculosis Epidemiologic Studies Consortium (TBESC). Examining the Impact of Disease and Patient Characteristics on Knowledge, Attitudes, and Beliefs among Foreign-born Tuberculosis Cases in the US and Canada. Journal of Immigrant and Minority Health 2013, Feb 26.
  • L. Freimanis Hance, K. Steingart, C. Hahn, L. Pascopella, and C. Nolan (2007). Field assessment of a model tuberculosis outbreak response plan for low-incidence areas . BMC Public Health 2007, 7:307.
  • Rachel Albalak, Richard J. O’Brien, J. Steve Kammerer, Sean M. O’Brien, Suzanne M. Marks, Kenneth G. Castro, Marisa Moore, Trends in Tuberculosis/Human Immunodeficiency Virus Comorbidity, United States, 1993-2004. Arch Intern Med 2007; 167(22).
  • Cook VJ, Sun SJ, Tapia J, Muth SQ, Arguello DF, Lewis BL, Rothenberg RB, McElroy PD. Transmission network analysis in tuberculosis contact investigations. J Infect Dis. 2007 Nov 15;196(10):1517-27. Epub 2007 Oct 31. PMID: 18008232
  • Lobato MN, Sun SJ, Moonan PK, Weis SE, Saiman L, Reichard AA, Feja K; Zero Tolerance for Pediatric TB Study Group. Underuse of effective measures to prevent and manage pediatric tuberculosis in the United States. Arch Pediatr Adolesc Med. 2008; 162(5):426-31
  • Katz D, Albalak R, Wing J.S., and Combs V. Setting the Agenda: A New Model for Collaborative Tuberculosis Epidemiologic Research. Tuberculosis 2007; 87: 1-6.
  • Li J., Marks SM, Driver CR, Diaz FA, Castro AF, Figueroa de Regner A, Gibson AE, Dokubo-Okereke K, Munsiff S. HIV Counseling, Testing, and Referral of Close Contacts to Patients with Pulmonary Tuberculosis: Feasibility and Costs. Journal of Public Health Management and Practice. 2007; 13(3).
  • Miller, T.L., P. Hilsenrath, K. Lykens, S.J.N. McNabb, P.K. Moonan, and S.E. Weis. Using Costs and Health Impacts to Prioritize the Targeted Testing of Tuberculosis in the United States. Ann Epidemiology 2006; 16(4):305-12.
  • Phillips, V L. Teweldemedhin, B. Ahmedov, S. Cobb, J. McNabb SJN. Evaluation of program performance and expenditures in a report of performance measures (RPM) via a case study of two Florida county tuberculosis program. Evaluation & Program Planning. 2010; 33(4):373-378.
  • Sterling T, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR, Tuberculosis Epidemiologic Studies Consortium. The Scope and Impact of Treatment of Latent Tuberculosis Infection in the United States and Canada. American Journal of Respiratory and Critical Care Medicine 2006: 173; 927-931.
  • C. Robert Horsburgh, Jr., Stefan Goldberg, James Bethel, Shande Chen, Paul Colson, Yael Hirsch-Moverman, Stephen Hughes, Robin Shrestha-Kuwahara, Timothy R. Sterling, Kirsten Wall, Paul Weinfurter and the Tuberculosis Epidemiologic Studies Consortium. Latent Tuberculosis Infection Treatment Acceptance and Completion in the United States and Canada.  Chest 2010; 137(2):401-409.
  • P. W. Colson, Y. Hirsch-Moverman, J. Bethel, P. Vempaty, K. Salcedo, K. Wall, W. Miranda, S. Collins, C. R. Horsburgh, for the Tuberculosis Epidemiologic Studies Consortium.   Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada.  The International Journal of Tuberculosis and Lung Disease. 17(4):473-479.
  • Kammerer, J. S., S.J.N. McNabb, J.E. Becerra, L. Rosenblum, N. Shang, M.F. Iademarco, and T.R. Navin. Tuberculosis Transmission in Nontraditional Settings: A Decision Tree Approach. Am J Prev Med 2005;28(2):201.
  • Jereb J, Albalak R, Castro KG. (2004) The Arden House Conference on Tuberculosis, Revisited: Perspectives for Tuberculosis Elimination in the United States. Seminars in Respiratory and Critical Care Medicine. 25(3): 255-269.
  • McNabb, S.J.N., J. S. Kammerer, A.C. Hickey, C.R. Braden, L. Rosenblum, N. Shang, and T. Navin. Added Epidemiologic Value to Tuberculosis Prevention and Control of the Investigation of Clustered Genotypes of Mycobacterium tuberculosis Isolates. Am J Epid. 2004; 160:589-97.
  • Marks SM, Cronin W, Venkatappa T, Maltas G, Chon S, Sharnprapai S, Gaeddert M, Tapia J, Dorman SE, Etkind S, Crosby C, Blumberg HM, Bernardo J. The Health-System Benefits and Cost-effectiveness of Using Mycobacterium Tuberculosis Direct Nucleic Acid Amplification Testing to Diagnose Tuberculosis Disease in the United States. Clinical Infectious Diseases.  2013;57(4);532-42.
  • Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, Parker M, Garrett DO, Daley CL; for the Tuberculosis Epidemiologic Studies Consortium. Interferon-γ Release Assays and Tuberculin Skin Testing for Diagnosis of Latent Tuberculosis Infection in Healthcare Workers in the United States. Am J Respir Crit Care Med. 2013 Dec 3. [Epub ahead of print] PubMed PMID: 24299555.
  • Y Hirsch-Moverman; K Wall; P Weinfurter; E Munk; J A Moran; A Maiuri; A Khan; N DeLuca for the TB Epidemiologic Studies Consortium. Acceptability of interferon-gamma release assays among healthcare workers who receive routine employee tuberculosis testing. International Journal of Occupational and Environmental Health (ISSN: 10773525). Appeared or available online: 02 August 2013
    DOI: 10.1179/2049396713Y.0000000038\
  • Marks SM, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, et al. Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005–2007. Emerg Infect Dis [Internet]. 2014 May.
Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC–INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Road Atlanta, GA 30329-4027, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #